ATE495758T1 - Virulentes systemisches felines calicivirus - Google Patents

Virulentes systemisches felines calicivirus

Info

Publication number
ATE495758T1
ATE495758T1 AT04720404T AT04720404T ATE495758T1 AT E495758 T1 ATE495758 T1 AT E495758T1 AT 04720404 T AT04720404 T AT 04720404T AT 04720404 T AT04720404 T AT 04720404T AT E495758 T1 ATE495758 T1 AT E495758T1
Authority
AT
Austria
Prior art keywords
feline calicivirus
virulent
calicivirus
fcv
systemic feline
Prior art date
Application number
AT04720404T
Other languages
English (en)
Inventor
Janet Foley
Kate Hurley
Niels Pedersen
Amy Poland
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Priority claimed from PCT/US2004/007677 external-priority patent/WO2004083390A2/en
Application granted granted Critical
Publication of ATE495758T1 publication Critical patent/ATE495758T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04720404T 2003-03-14 2004-03-12 Virulentes systemisches felines calicivirus ATE495758T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/388,837 US7309495B2 (en) 2003-03-14 2003-03-14 Hemorrhagic feline calicivirus
US10/769,531 US7264816B2 (en) 2003-03-14 2004-01-30 Virulent systemic feline calicivirus
PCT/US2004/007677 WO2004083390A2 (en) 2003-03-14 2004-03-12 Virulent systemic feline calicivirus

Publications (1)

Publication Number Publication Date
ATE495758T1 true ATE495758T1 (de) 2011-02-15

Family

ID=32962139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04720404T ATE495758T1 (de) 2003-03-14 2004-03-12 Virulentes systemisches felines calicivirus

Country Status (10)

Country Link
US (3) US7309495B2 (de)
EP (1) EP2301574A1 (de)
JP (1) JP4724112B2 (de)
AT (1) ATE495758T1 (de)
CY (1) CY1111521T1 (de)
DE (1) DE602004031092D1 (de)
DK (1) DK1606391T3 (de)
ES (1) ES2358798T3 (de)
NZ (1) NZ541449A (de)
PT (1) PT1606391E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
GB0603749D0 (en) * 2006-02-24 2006-04-05 Moving Sun Ltd Immune system stimulant and process of manufacturing the same
JP2010528603A (ja) * 2007-05-30 2010-08-26 ワイス・エルエルシー ネコ抗原のアライグマポックスウイルス発現遺伝子
US10188725B2 (en) 2015-12-14 2019-01-29 Elanco Us Inc. Hybrid core feline vaccines
RU2628096C1 (ru) * 2016-06-01 2017-08-14 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Штамм Эшли вируса калицивироза кошек для изучения противовирусной активности препаратов в отношении калицивироза кошек
EP3706790A1 (de) 2017-11-06 2020-09-16 Intervet International B.V. Multivalenter impfstoff für katzen
WO2019115090A1 (en) 2017-12-15 2019-06-20 Intervet International B.V. Multivalent feline vaccine
US11229699B2 (en) 2017-11-06 2022-01-25 Intervet Inc. Feline calicivirus vaccine
AU2018380582B2 (en) 2017-12-08 2025-08-14 Intervet International B.V. Feline calicivirus vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3937812A (en) * 1974-11-21 1976-02-10 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3992520A (en) * 1974-11-27 1976-11-16 Merck & Co., Inc. Anti-fertility vaccine comprising solubilized zona pellucida and anti-serum
US4522810A (en) * 1982-12-09 1985-06-11 The Regents Of The University Of California Feline calicivirus vaccine
US4795634A (en) * 1986-03-14 1989-01-03 Aphton Corporation Method for contraception by immunization against the zona pellucida
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
US5716822A (en) * 1989-07-21 1998-02-10 Pharmacia & Upjohn Company Feline calicivirus capsid gene and protein
AU661106B2 (en) * 1992-02-28 1995-07-13 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
ATE275191T1 (de) * 1992-11-09 2004-09-15 Zonagen Inc Methoden für die immunoempfängnisverhütung
US6231863B1 (en) * 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
US6355246B1 (en) * 1999-06-10 2002-03-12 Board Of Trustees Of Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof

Also Published As

Publication number Publication date
US7264816B2 (en) 2007-09-04
US7449323B2 (en) 2008-11-11
NZ541449A (en) 2009-01-31
EP2301574A1 (de) 2011-03-30
US20080063663A1 (en) 2008-03-13
US20040180064A1 (en) 2004-09-16
US7309495B2 (en) 2007-12-18
PT1606391E (pt) 2011-04-01
ES2358798T3 (es) 2011-05-13
DK1606391T3 (da) 2011-03-21
JP2006524503A (ja) 2006-11-02
CY1111521T1 (el) 2014-02-12
US20040259225A1 (en) 2004-12-23
DE602004031092D1 (de) 2011-03-03
JP4724112B2 (ja) 2011-07-13

Similar Documents

Publication Publication Date Title
WO2006031795A3 (en) Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
NO345071B1 (no) Farmasøytisk preparat og anvendelse derav
CY1117963T1 (el) Αντισωματα που προσδενουν τα il-17a και il-17f
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
DE602004024542D1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
CY1111521T1 (el) Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων
DK1881845T3 (da) Nipah-virusvacciner
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
ATE521621T1 (de) Cpg-einzelstrang-desoxynukleotide zur verwendung als adjuvans
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
AR047581A1 (es) Vacunas de calicivirus felino
RU2020109137A (ru) Вакцина для защиты от streptococcus suis
WO2004083390A3 (en) Virulent systemic feline calicivirus
DK2050463T3 (da) Vaccinesammensætning til vaccination af hunde mod hundeinfektiøs respiratorisk sygdom (CIRD)
EP1543838A4 (de) Vakzine gegen infektiöse katzen-peritonitis
AR056712A1 (es) Composicion y vacuna efectiva para tratar prevenir o mejorar la inoculacion del virus de la influenza canina metodo pra generar un inmunogen del virus dela influenza equina o del virus de la influenza canina modelo de la inoculacion util para determinar la eficacia de la composicion contra el virus
NO20060976L (no) Vaksine
DK1657248T3 (da) Vaccine til forebyggelse og behandling af svine-progressiv atrofisk rhinitis
WO2004043286A3 (en) Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen
NO20060395L (no) Antigenholdig dyrevaksine
ATE431745T1 (de) Ltb4 als adjuvans für impfstoffe
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
CY1114309T1 (el) Εμβολιο ροταϊου
CY1116907T1 (el) Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1606391

Country of ref document: EP